These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35188303)
21. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy. Fortin JS; Hetak AA; Duggan KE; Burglass CM; Penticoff HB; Schott HC Sci Rep; 2021 Aug; 11(1):16036. PubMed ID: 34362943 [TBL] [Abstract][Full Text] [Related]
22. Laboratory diagnosis of equine pituitary pars intermedia adenoma. van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ Domest Anim Endocrinol; 1995 Jan; 12(1):35-9. PubMed ID: 7621678 [TBL] [Abstract][Full Text] [Related]
23. Role of MRI T2-DRIVE in the assessment of pituitary stalk abnormalities without gadolinium in pituitary diseases. Godano E; Morana G; Di Iorgi N; Pistorio A; Allegri AEM; Napoli F; Gastaldi R; Calcagno A; Patti G; Gallizia A; Notarnicola S; Giaccardi M; Noli S; Severino M; Tortora D; Rossi A; Maghnie M Eur J Endocrinol; 2018 Jun; 178(6):613-622. PubMed ID: 29650689 [TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance for evaluation of neurologic disease in 12 horses. Ferrell EA; Gavin PR; Tucker RL; Sellon DC; Hines MT Vet Radiol Ultrasound; 2002; 43(6):510-6. PubMed ID: 12502103 [TBL] [Abstract][Full Text] [Related]
25. Obesity and pituitary gland volume - a correlation study using three-dimensional magnetic resonance imaging. Fehrenbach U; Jadan A; Auer TA; Kreutz K; Geisel D; Ziagaki A; Bobbert T; Wiener E Neuroradiol J; 2020 Oct; 33(5):400-409. PubMed ID: 32666872 [TBL] [Abstract][Full Text] [Related]
26. Imaging and histological features of central subchondral osteophytes in racehorses with metacarpophalangeal joint osteoarthritis. Olive J; D'Anjou MA; Girard C; Laverty S; Theoret CL Equine Vet J; 2009 Dec; 41(9):859-64. PubMed ID: 20383982 [TBL] [Abstract][Full Text] [Related]
27. Computed tomography and low-field magnetic resonance imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism: 11 cases (2001-2003). Auriemma E; Barthez PY; van der Vlugt-Meijer RH; Voorhout G; Meij BP J Am Vet Med Assoc; 2009 Aug; 235(4):409-14. PubMed ID: 19681723 [TBL] [Abstract][Full Text] [Related]
28. Perianesthetic development of diaphragmatic hernia in a horse with equine pituitary pars intermedia dysfunction (PPID). Shepard MK; Lee WL; Eggleston RB Can Vet J; 2015 Jan; 56(1):48-52. PubMed ID: 25565714 [TBL] [Abstract][Full Text] [Related]
30. The neuroimaging features of Rathke's cleft cysts in children with endocrine-related diseases. Güneş A; Özbal Güneş S Diagn Interv Radiol; 2020 Jan; 26(1):61-67. PubMed ID: 31670263 [TBL] [Abstract][Full Text] [Related]
31. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992). van der Kolk JH; Kalsbeek HC; van Garderen E; Wensing T; Breukink HJ Vet Rec; 1993 Dec; 133(24):594-7. PubMed ID: 8116170 [TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging features of equine nigropallidal encephalomalacia. Sanders SG; Tucker RL; Bagley RS; Gavin PR Vet Radiol Ultrasound; 2001; 42(4):291-6. PubMed ID: 11499702 [TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging of a brain abscess in a 10-month-old filly. Audigié F; Tapprest J; George C; Didierlaurent D; Foucher N; Faurie F; Houssin M; Denoix JM Vet Radiol Ultrasound; 2004; 45(3):210-5. PubMed ID: 15200257 [TBL] [Abstract][Full Text] [Related]
34. Lamellar pathology in horses with pituitary pars intermedia dysfunction. Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529 [TBL] [Abstract][Full Text] [Related]
35. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses. McFarlane D; Cribb AE Am J Vet Res; 2005 Dec; 66(12):2065-72. PubMed ID: 16379648 [TBL] [Abstract][Full Text] [Related]
36. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction. Copas VE; Durham AE Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531 [TBL] [Abstract][Full Text] [Related]
37. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction. Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404 [TBL] [Abstract][Full Text] [Related]
38. Occurrence of primary lymphocytic hypophysitis in two horses and presence of scattered T-lymphocytes in the normal equine pituitary gland. Grau-Roma L; Peckham R; Paton J; Stahel A; de Brot S J Vet Diagn Invest; 2017 Jan; 29(1):115-121. PubMed ID: 27852816 [TBL] [Abstract][Full Text] [Related]
39. INTRAARTERIAL INJECTION OF IODINATED CONTRAST MEDIUM FOR CONTRAST ENHANCED COMPUTED TOMOGRAPHY OF THE EQUINE HEAD. Carmalt JL; Montgomery J Vet Radiol Ultrasound; 2015; 56(4):384-90. PubMed ID: 25782997 [TBL] [Abstract][Full Text] [Related]
40. A machine learning model to precisely immunohistochemically classify pituitary adenoma subtypes with radiomics based on preoperative magnetic resonance imaging. Peng A; Dai H; Duan H; Chen Y; Huang J; Zhou L; Chen L Eur J Radiol; 2020 Apr; 125():108892. PubMed ID: 32087466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]